Faculty of Life Sciences, The University of Manchester, Manchester, UK.
Toxicol In Vitro. 2011 Mar;25(2):433-45. doi: 10.1016/j.tiv.2010.11.007. Epub 2010 Nov 17.
Allergic diseases of the skin and respiratory tract resulting from exposure to low molecular weight chemicals remain important issues for consumer product development and occupational/environmental health. Widespread opportunities for exposure to chemical allergens require that there are available effective methods for hazard identification and risk assessment. In the search for new tools for hazard identification/characterization there has been interest in developing alternative methods that will reduce, refine or replace the need for animals. One approach that shows promise is based on the measurement of the peptide reactivity of chemicals; the potential to form stable associations with protein/peptide being a key requirement for the induction of sensitization. Recent investigations using these systems have focused primarily on skin sensitizing chemicals. However, there is interest in the possibility of exploiting these same experimental approaches to distinguish between different forms of chemical allergens - as individual materials are primarily associated with one or the other form of sensitization in humans. These investigations may also provide insight into why chemical sensitizers can differ in the form of allergic disease they will preferentially induce. These opportunities are surveyed here against a background of the immunobiology of allergic sensitization and current state-of-the-art approaches to measurement of peptide/protein reactivity.
由于接触低分子量化学物质而导致的皮肤和呼吸道过敏疾病仍然是消费品开发和职业/环境健康的重要问题。广泛的接触化学过敏原的机会要求有有效的危险识别和风险评估方法。在寻找新的危险识别/特征描述工具时,人们一直对开发替代方法感兴趣,这些方法将减少、改进或取代对动物的需求。一种有前景的方法是基于测量化学物质的肽反应性;与蛋白质/肽形成稳定结合的能力是诱导致敏的关键要求。最近使用这些系统的研究主要集中在皮肤致敏化学物质上。然而,人们有兴趣利用这些相同的实验方法来区分不同形式的化学过敏原,因为个体材料主要与人类的一种或另一种致敏形式相关。这些研究还可能深入了解为什么化学敏化剂在它们优先诱导的过敏疾病形式上会有所不同。在过敏致敏的免疫生物学和肽/蛋白质反应性测量的最新方法的背景下,本文对此进行了调查。